Monosodium Risedronate Hemipentahydrate
98.0%
- Product Code: 61938
CAS:
329003-65-8
Molecular Weight: | 305.09 g./mol | Molecular Formula: | C₇H₁₀NNaO₇P₂₂₁₂H₂O |
---|---|---|---|
EC Number: | MDL Number: | MFCD01706268 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Monosodium Risedronate Hemipentahydrate is primarily used in the treatment of bone-related disorders. It is effective in managing osteoporosis by increasing bone density and reducing the risk of fractures. This compound is also utilized in treating Paget's disease, a condition characterized by abnormal bone remodeling. Additionally, it aids in preventing bone loss in patients undergoing certain medical treatments, such as long-term corticosteroid therapy. Its mechanism involves inhibiting osteoclast-mediated bone resorption, thereby promoting bone strength and stability.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.250 | 10-20 days | $406.38 |
+
-
|
Monosodium Risedronate Hemipentahydrate
Monosodium Risedronate Hemipentahydrate is primarily used in the treatment of bone-related disorders. It is effective in managing osteoporosis by increasing bone density and reducing the risk of fractures. This compound is also utilized in treating Paget's disease, a condition characterized by abnormal bone remodeling. Additionally, it aids in preventing bone loss in patients undergoing certain medical treatments, such as long-term corticosteroid therapy. Its mechanism involves inhibiting osteoclast-mediated bone resorption, thereby promoting bone strength and stability.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :